Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG36883

KDM5B Knockout TE1 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

The KDM5B Knockout TE1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population of human TE1 esophageal squamous cell carcinoma cells, featuring targeted disruption of the KDM5B gene. KDM5B is a histone H3K4 demethylase and transcriptional repressor that regulates gene expression, stem cell maintenance, and tumorigenesis, functioning downstream of MYC, WNT, and Notch signaling and interacting with SIN3A and PRC2 complexes. The knockout cells enable functional genomics, drug screening, and chromatin remodeling research, supporting assays such as Western blotting, RT-qPCR, ChIP-qPCR, and cell-based functional analyses. Researchers can explore KDM5B??s role in esophageal squamous cell carcinoma and other cancers.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    TE1

    Gene Name

    KDM5B

    Gene Identifier

    NCBI Gene ID 10765

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The KDM5B Knockout TE1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population of TE1 human esophageal squamous cell carcinoma cells with targeted disruption of the KDM5B gene. This model provides a heterogeneous pool of loss-of-function alleles for functional studies without clonal selection, enabling robust analysis of KDM5B-dependent phenotypes in a cancer context.

The TE1 cell line is an epithelial model of human esophageal squamous cell carcinoma, commonly employed for investigating tumorigenesis, drug responses, and molecular mechanisms of this malignancy. Its genetic characteristics make it a valuable host for knockout studies examining genes involved in esophageal cancer progression and treatment resistance.

KDM5B encodes a histone H3K4me2/me3 demethylase that acts as a transcriptional repressor, forming complexes with SIN3A, HDAC1/2, REST, and Polycomb repressive complex 2 (PRC2) components such as EZH2 to silence gene expression. Its activity is regulated by MYC, HIF1A, NOTCH1, WNT signaling, and miR-137, and it represses targets including CCND1, CDKN1A, CDH1, and HOX genes. Through these interactions, KDM5B controls cell proliferation, differentiation, stem cell self-renewal, and epithelial-mesenchymal transition, with dysregulation contributing to cancer.

In TE1 cells, KDM5B knockout disrupts the demethylase function underlying tumor aggressiveness and cancer stem cell maintenance. This model permits dissection of KDM5B’s roles in esophageal squamous cell carcinoma growth, EMT, and histone modification dynamics, as well as its crosstalk with MYC and Notch pathways. Epigenetic and phenotypic changes following knockout can be systematically assessed to elucidate its contribution to tumor biology.

Applications include functional genomics, epigenetic drug screening, and chromatin remodeling studies. The cells support standard assays such as Western blotting for histone marks and protein levels, RT-qPCR, ChIP-qPCR, immunofluorescence, and functional assays assessing proliferation, migration, and colony formation. For more information, contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)